Ranolazine Tablet, Film Coated, Extended Release
Product Images NDC 71610-971

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ranolazine (NDC 71610-971). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (71610 0971 42)

Ranolazine ER 500 mg extended release film-coated tablets packaging label. The label indicates a 1800 tablet count. Labeler information shows Aphena Pharma Solutions - Tennessee, LLC located in Cookeville, TN, with manufacturing by ScieGen Pharmaceuticals Inc in Hauppauge, NY. The label includes storage instructions and regulatory details but does not show specific expiration dates or lot numbers.*

FDA Label Image

Aphena (Aphena)

FDA Label Image

Chemical Structure (Ranolazine Str)

Chemical structure diagram of ranolazine, illustrating the molecular configuration including phenyl groups, ether and amide functional groups, and a piperazine ring.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.